The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Valamehr Bahram since 2019.
This trader's CIK number is 1748177.
At the time of last reporting, Valamehr Bahram was the President and CEO of Fate Therapeutics Inc. (stock ticker symbol FATE).
Also see all insider trading activities at Fate Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | FATE | 0 | $0 | 23,171 | $28,796 | 0 | $0 |
| 2024 | FATE | 0 | $0 | 11,271 | $49,366 | 0 | $0 |
| 2022 | FATE | 0 | $0 | 60,166 | $2,048,280 | 50,000 | $144,772 |
| 2021 | FATE | 0 | $0 | 109,484 | $8,508,955 | 100,000 | $279,375 |
| 2020 | FATE | 0 | $0 | 55,700 | $3,507,900 | 51,153 | $131,823 |
| 2019 | FATE | 0 | $0 | 6,200 | $87,891 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-04 | FATE | Sale | 14,466 | 1.06 | 15,391 |
| 2025-01-10 | FATE | Sale | 8,705 | 1.54 | 13,405 |
| 2024-01-09 | FATE | Sale | 11,271 | 4.38 | 49,366 |
| 2022-07-07 | FATE | Option Ex | 17,158 | 2.73 | 46,841 |
| 2022-07-07 | FATE | Sale | 17,158 | 30.23 | 518,686 |
| 2022-07-06 | FATE | Option Ex | 7,842 | 3.79 | 29,681 |
| 2022-07-06 | FATE | Sale | 7,842 | 30.07 | 235,808 |
| 2022-03-14 | FATE | Option Ex | 25,000 | 2.73 | 68,250 |
| 2022-03-14 | FATE | Sale | 25,000 | 32.37 | 809,249 |
| 2022-01-11 | FATE | Sale | 4,570 | 48.78 | 222,924 |
| 2022-01-10 | FATE | Sale | 5,596 | 46.75 | 261,613 |
| 2021-12-13 | FATE | Option Ex | 25,000 | 2.73 | 68,250 |
| 2021-12-13 | FATE | Sale | 25,000 | 47.61 | 1,190,150 |
| 2021-09-13 | FATE | Option Ex | 25,000 | 2.73 | 68,250 |
| 2021-09-13 | FATE | Sale | 25,000 | 66.75 | 1,668,649 |
| 2021-06-14 | FATE | Sale | 25,000 | 89.85 | 2,246,200 |
| 2021-06-14 | FATE | Option Ex | 25,000 | 2.81 | 70,375 |
| 2021-03-15 | FATE | Option Ex | 25,000 | 2.90 | 72,500 |
| 2021-03-15 | FATE | Sale | 25,000 | 92.76 | 2,319,100 |
| 2021-01-08 | FATE | Sale | 6,230 | 116.33 | 724,717 |
| 2021-01-11 | FATE | Sale | 3,254 | 110.68 | 360,139 |
| 2020-12-14 | FATE | Sale | 25,000 | 99.32 | 2,483,100 |
| 2020-12-14 | FATE | Option Ex | 25,000 | 2.90 | 72,500 |
| 2020-09-14 | FATE | Option Ex | 25,000 | 2.29 | 57,375 |
| 2020-09-14 | FATE | Sale | 25,000 | 36.27 | 906,850 |
| 2020-02-03 | FATE | Option Ex | 1,153 | 1.69 | 1,948 |
| 2020-01-08 | FATE | Sale | 5,700 | 20.69 | 117,950 |
| 2019-10-15 | FATE | Sale | 6,200 | 14.18 | 87,891 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valamehr Bahram (President and CEO of Fate Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.